Abbott Laboratories new rapid test for the Coronavirus strain Covid-19 should expand much-needed access and help fill in gaps where U. S. testing has been slow and still unavailable months into the pandemic.
Studies have shown that sufferers have had to wait an average of seven and a half years before getting answers from clinicians about the symptoms and a diagnosis of endometriosis.
Incentivizing physicians to prescribe expensive brand-name chemotherapies instead of generic ones risks burdening patients with high out-of-pocket costs.
Since the start of the Covid19 pandemic, there has been endless discussion on how to protect the public. As it turns out, the key to reopening maybe simple math.
Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”
With patients paying more out-of-pocket costs for medical expenses than ever before, it’s high time health-care providers publicly post prices for every aspect of medical care.
Abbott Laboratories won Food and Drug Administration emergency clearance for its portable test for the coronavirus strain Covid-19 that will sell for just $5 and allow for “frequent mass testing” in schools and workplaces, the company said.
The American Medical Association wants to be sure the U. S. Food and Drug Administration is transparent and “continuously” informing physicians about its review process for a vaccine for the Coronavirus strain Covid-19.